l objective: late-stage lymphoedema is characterised by chronic swelling, shape distortion, inflammatory processes and tissue fibrosis. our aim was to perform a clinical audit of a lymphoedema compression bandaging system (rosidal soft foam roll layer and figure-of-eight application of actico cohesive inelastic bandages) specifically designed for patients with late stage lower limb lymphoedema. l Method: the audit explored suitability of the bandaging system, benchmarking limb volume changes with research evidence, and reporting patient and practitioner evaluations. l results: a mean reduction (33%) in excess limb volume was reported for the 11 patients with unilateral lymphoedema who completed a course of bandaging over 12 days. mean percentage reduction of absolute limb volume after treatment was 8%. patient and practitioner evaluations indicated the suitability of this bandage system for patients with late stage lymphoedema in terms of comfort and effectiveness. l conclusion: the bandaging system is suitable for patients with late stage chronic swelling. two parameters for calculating change in limb volume are not interchangeable.. future evaluation of the bandaging system, using validated outcome measures within a comprehensive research study is required. l declaration of interest: activa healthcare provided financial support to the project and supplied the materials. L ymphoedema develops when the lymphatic system fails to effectively drain areas of the skin and tissues due to various primary and acquired causes.
1 This leads to tissue fluid stasis, changes in immune function and impaired fat metabolism. 2 Late stage lymphoedema is characterised by persistent swelling, shape distortion, inflammatory processes, fat deposition, and chronic tissue fibrosis (Table 1) . 3 These compromise skin integrity, further damage lymphatics, and significantly influence quality of life.
This paper reports on a clinical audit of a lymphoedema compression bandaging system, Rosidal Soft foam roll layer and figure-of-eight application of Actico cohesive inelastic bandages, specifically designed for patients with late stage (≥ Stage IIb) lower-limb lymphoedema.
compression bandaging for lymphoedema
Inelastic bandaging systems are commonly used in combination with skin care, manual lymph drainage (MLD) and exercises, to decongestive, reduce limb swelling, restore a natural limb shape, and improve the condition of the skin and tissues in patients with lymphoedema. Compression bandaging has various effects (Table 2) . 4 Pressures exerted by a bandage system are influenced by a variety of factors including: the physical and elastomeric properties of the bandage components; application technique; skill of the bandager; and the dimensions of the limb. 5 Conditions such as chronic tissue fibrosis may influence the action of a bandaging system, although evidence is limited, and quantifying tissue change is challenging. Above all, patients require a stable, comfortable and clinically effective bandaging system that promotes movement and is readily tolerated.
Partsch and Moffatt 4 describe the use of 'intelligent' compression products, such as inelastic or 'stiff' bandages that do not yield to changes in limb shape, as an elastic system would. A high static stiffness index (SSI) (Table 3) , calculated as the difference in sub-bandage pressures when the patient moves between supine and standing, is an indication that clinically effective pressure variations are being achieved, influencing the vascular and lymphatic systems. 4 Previously, we showed that the system incorporating a soft foam roll and cohesive inelastic bandages in figure-of-eight application provided stiffness, with significant variations in pres- (Table 3) . 6 Importantly, the combination of the foam roll and cohesive inelastic bandage, with unique textile properties, also provided an easily applied, nonbulky and comfortable compression system. 6 However, more information is required on the effectiveness of the system in patients with late stage lymphoedema.
Materials and methods

audit process
The audit took place within four lymphoedema centres in the UK and involved seven experienced lymphoedema practitioners who were familiar with a range of different bandage systems. The protocol was reviewed by local R&D offices for each centre. As this was an audit, incorporating routine clinical treatments and outcome measures, the activity was identified as not requiring ethical approval in each location.
Experienced lymphoedema practitioners recruited patients to the audit using a screening form to assess eligibility and suitability for compression bandaging. Patients suitable to take part were given written information about the audit. Individuals were eligible if they were over 18 years of age, had ≥Stage II unilateral lymphoedema of the leg requiring bandaging. Those who were pregnant, had relevant heart, kidney or liver disease, acute infection, arterial insufficiency, deep vein thrombosis within the previous three months, or were known to be allergic to the study materials were excluded. Individuals with lymphoedema gave written informed consent before taking part, and were advised that they could withdraw at any point. All audit data were kept anonymous, and files stored in a locked cabinet.
The bandaging system
Patients were bandaged over a two week period using a method previously developed from work with 18 healthy volunteers (Fig 1) .
6 Lymphoedema practitioners were given information on the bandaging protocol, with additional training provided as required.
The system
• Rosidal Soft (Activa Healthcare Ltd) foam rolls (10cm and 12cm width) were applied to the limb in a spiral technique with minimal overlap. The foam roll is 0.4cm in depth, providing a stable padding layer that is protective but is non-bulky, enabling patients to wear shoes, and promoting movement of the joints. This is less bulky than layers of wadding material, and may be more suitable for some patients, particularly those who are very active, and those with tissue fibrosis. • stockinette layer • additional wadding/padding out of deep skin folds with cellona • toe bandage: mollellast or similar • cushion of padding/wadding behind the knee to reduce friction against moving tendons.
foam layer apply a 10cm foam, starting foam at the lateral aspect of the foot at the base of the little toe. Wrap over dorsum of the foot, and around foot, using spiral application, keeping overlap to a minimum.
Wrap foam over the ankle and continue up the leg, with an approximate 1.5cm overlap. at the achilles area, you may need to make a tuck/pleat in the foam so it lies as flat as possible behind the ankle. the 10cm usually runs out just below the knee; continue with a 12cm roll of foam to the top of the limb, cutting an additional section from a new roll of 12cm if required at the top of the thigh. apply a slim stockinette pad filled with cellona in the popliteal area and/or to reshape where required. cohesive inelastic bandage layer ask person to dorsiflex; start with 8cm or 10cm bandage, depending on foot length. Begin at lateral foot, turning under sole and over dorsum of foot. Wrap ankle and foot with figureof-eight application, to suit foot shape and size. continue with figure-of-eight application up the leg using a 50% overlap, changing from 8cm, to 10cm and 12cm as required (bandages can be cut). apply according to manufacturer instructions; keep the bandage roll close to the leg, and apply at full stretch.
• Actico cohesive short stretch bandages (Activa Healthcare Ltd) applied at full stretch, in a figure-ofeight technique, using sizes 8cm, 10cm and 12cm, according to individual need. The figure-of-eight application provides higher pressures than the spiral technique, and also avoids excessive bulk, where for example, two spiral layers were previously used.
The protocol required practitioners to apply the bandage system on six occasions at days 1, 2, 3, 5, 8 and 10, using a new set of bandaging components.. Individual patient records were kept to record the materials used and any changes made to the bandaging system at each application. Toe bandages, stockinette liners, and additional padding such as wadding behind the knee were applied according to individual clinical need, at the discretion of the clinician, and noted on the patient record. Similarly, MLD and other therapies such as intermittent compression were used according to clinical need and recorded. This reflected the audit aims of exploring the suitability of the bandage system within routine patient care, rather than a robust research protocol.
At day 12 bandages were removed and compression garments fitted. Although some patients will require longer periods of treatment, it was felt by the team that a 12 day audit period was a suitable timescale, reflecting treatment programmes in many lymphoedema clinics. Daily bandage application in the first few days of the treatment course allowed for regular assessment of the patient and the condition of their skin and tissues, particularly Table 2 . effects of compression bandaging
• reducing capillary filtration reducing the volume of fluid entering the tissues • increasing venous flow velocity, reducing venous reflux and ambulatory venous pressures
• increasing lymph drainage and reducing lymphatic hypertension
• shifting fluid to non-compressed areas across tissue planes
• reducing inflammatory processes, fibrosclerosis, lipodermatosclerosis and associated damage to local lymphatics as the greatest oedema volume reduction may be expected within the first week.
audit methods
A number of routine outcome measures were used. Volumetry: limb volume of both legs was recorded at day 1 and day 12 for each patient, according to usual practice at each clinic, using one of the following two methods: l Limb circumference measured at 4cm intervals along both limbs, allowing calculation of limb volume using the formula for the volume of a cylinder (V = πr 2 h) or l Use of the Perometer (an infra-red scanning device) used at one clinic to provide details of absolute limb volume of both limbs.
As the patients all had unilateral lymphoedema, the excess limb volume was then calculated as the difference between the non-swollen and swollen limb, expressed in millilitres, and also as a percentage of the volume of the non-swollen limb (Table 4) . Two parameters for calculating volume reduction between Day 1 and 12 (Table 4) were then applied.
Assessment of tissue score: this was assessed at day 1 and day 12 using a simple descriptive scoring system commonly used on lymphoedema assessment forms, identifying the severity of tissue fibrosis and presence of skin conditions, including cellulitis. The tool was adapted from the '5 S' scoring system originally developed by Caroline Badger as part of a Macmillan Project. 7 It had a score range of 0-27, with a higher score denoting more complex skin and tissue problems.
Bandage slippage: the skin was marked to indicate the top of the bandage after application, and the amount of slippage was measured and recorded in centimetres at each bandage change before removing the system.
Practitioner questionnaires: practitioners completed simple rating scales to evaluate ease of bandage application and removal, and perceived effectiveness of the bandaging system at day 12.
Patient evaluations: patients completed simple rat-ing scales to give feedback on the comfort of the bandage system at day and night, ease of ankle movement, and ability to wear footwear at day 1, 5 and 12.
Results
Patient characteristics
A total of 12 patients with unilateral lower limb lymphoedema took part in the audit between February and December 2013 (Table 5 ). This included six men and six women with a mean age of 49 years (range: 32-73 years). Of the patients included in the audit, one patient (8%) had cancer-related lymphoedema and eleven (92%) had non-cancer-related lymphoedema. Lymphoedema was present for more than 6 years in nine patients, the probable reason for progression to ≥Stage IIb lymphoedema (ISL 2013). 3 Of the total 12 patients in the study, seven (58%) had previous experience of undergoing a course of bandaging, and five patients (42%) had no previous experience of bandaging.The mean weight of 11 individuals for whom data were available was 85.7kg (range: 65.5-154.0kg). Mean BMI for seven patients, where the data was available, was 34.7 (range: 24.0-56.6). Patient ID11 withdrew at day 8 due to skin irritation.
frequency of bandage application
A total of 66 applications of the bandaging system were used across the audit period in the 12 patients. Other treatments included: skin care (n =12), manual lymph drainage (n=6) and pneumatic compression (n=3). Over the two week audit period, nine patients had six applications of the system. Fewer applica- tions were made in three patients (Table 5) , and one of these withdrew at day 8. Four of the seven lymphoedema practitioners used the bandaging system on only one patient during the audit period. Toe bandaging was undertaken in 51/66 (72%) of the bandaging episodes.
limb volumetry
For the 11 patients who completed the audit, the mean excess limb volume (difference between unaffected and affected limb volume) was 3,274ml at day 1, and 2,310ml at day 12 (Table 6 ). The mean excess volumes expressed as a percentage of the unaffected limb volume were 38% at day 1, and 26% at day 12 (Table 6 ).
The mean reduction in excess limb volume for the 11 patients who completed was 964ml (range 339-2,465ml; SD 606). This represented a mean 33% reduction (range: 11-52%; SD 18.81) in the excess limb volume, when expressed as a percentage of the mean excess limb volume at day 1. Interestingly, when the excess limb volume changes were calculated for the patients who had MLD, the mean percentage reduction in excess limb volume is 44%, although the numbers are too small to explore the significance of this finding (n=6).
The mean absolute limb volume of the affected limb in the 11 patients who completed to day 12 was 11,993ml (range: 8,631-17,039ml; Table 7 ) at day 1, and 11,041ml (range: 7394-16,222ml) at day 12. This represented a mean reduction in absolute limb volume of 952ml (range: 339-2,468ml; SD 588.86). Expressed as a percentage of the baseline absolute limb volume the mean reduction in limb volume was 8% (range: 3-18%; SD 4.69).
change in tissue score
From a possible score of 27, the 11 patients who completed the audit had a mean score of 7.2 (range: 3-13) at day 1, reduced to 4.8 (range: 1-10) at day 12. The scoring system did not yield particularly detailed information on the degree of chronic skin and tissue problems such as fibrosis.
Anecdotal comments about skin condition during the period of bandaging, indicated that three patients had a mild skin reaction, including two who had temporary skin reddening when the bandage was removed. This skin reaction resolved very quickly. There were three reported instances of mild folliculitis and no incidence of cellulitis.
Bandage slippage
The degree of slippage was recorded in 52 instances from the total of 66 bandage applications: l No slippage: § n=14 l Minimal slippage (<5cm): n=26 l Moderate slippage (5-10cm): n=10 l Severe slippage (>10cm): n=2 Practitioner comments indicated that the foam roll applied without a stockinette layer provided skin contact and greater stability of the system, possibly preventing slippage. However, slippage may occur with any bandage system when the limb reduces in size due to oedema reduction, particularly at the start of a course of treatment. In 14 instances after the bandage system was removed, the practitioners did not complete this section.
Patient evaluations
The simple patient self-reported rating scales were developed to provide feedback from patients (Table  8) . These indicated that mean scores for comfort at day and night, ease of walking and moving, and 14,199 -9,507 = 4,692mls % excess limb volume is: 4,692/9,507 x 100 = 49%
Parameter 1: calculating change in excess volume change in excess limb volume between baseline and end of treatment was calculated as:
• the absolute change in excess limb volume ankle movement were favourable, and improved over the course of bandaging. Additional comments from patients who took part in the audit are provided in Table 9 .
Practitioner ratings
The practitioner ratings are reported in Fig 2a-h, and show that the system scored highly for perceived effectiveness, ease of application and removal, and simplicity for training or learning. Where practitioners were asked to compare this system to others, they rated the system relatively highly. In one instance, the practitioner who treated patient ID11 (who withdrew due to skin irritation) identified the system as not effective. Examples of general comments provided by the practitioners are reported in Table 9 .
Discussion
The findings of this small audit indicate the feasibility of using the bandaging system in terms of application and removal by the practitioner, comfort and movement for the patient. A lymphoedematous limb may become heavy and awkward. A bandage system must therefore promote natural movement and walking. The application of the soft foam in a spiral appears to provide an easily applied, comfortable, and clinically effective layer without excessive bulk, when combined with figure-of-eight application of the Actico bandage. In terms of clinical effectiveness, the audit findings relating to limb volume change can be benchmarked against research findings. Our reported percentage change in mean excess limb volume (33%) is identical to that achieved in a previous study of 34 patients following an 18-day course of bandaging using cotton short stretch (inelastic) bandages, 8 where patients were bandaged daily from Monday to Friday. It is lower than the 42% reduction in excess limb volume reported in 18 patients with leg lymphoedema immediately after decongestive treatment combining MLD, inelastic bandages and exercises, provided over an average treatment period of 8 days.
9 However, as there are inconsistencies in the measuring and reporting of limb volume in the literature, 10 direct comparison of results is difficult. Change in absolute limb volume can also be calculated, particularly in studies of patients with bilateral limb lymphoedema where there is no comparator 'normal' limb. In this audit we reported the mean reduction in absolute volume of the affected limbs as 952ml or 8% pretreatment affected limb volume. This is similar to the 870ml (SD 454) and 10.87% (SD 5.20) mean reduction in the volume of leg lymphoedema in eight patients following 15 applications of cotton short stretch (inelastic) bandaging reported in another study.
11
In the same study, Moffatt et al.
11 reported a mean absolute volume reduction of 1,552ml (SD 1221), representing a mean 18.65% (SD 14.50) reduction in swollen leg volume in patients undergoing twice weekly treatment with a two-layer bandaging system for six applications. In a report of 16 patients with leg lymphoedema, Franks et al.
12 reported a mean volume reduction of 1,596ml (95% CI: 1039-2153) and a percentage change in absolute limb volume of 14.9% (SD 9.9) following treatment with the same two layer system over a 19-day treatment period.
Caution must be taken in interpreting and comparing the limb volume results of different studies of bandaging. As shown in Table 4 , in patient ID12, the 32% reduction in excess volume is very different to the 10% reduction in absolute limb volume of the swollen leg. Clearly these two methods are not interchangeable. Researchers must therefore accurately record the parameters used for calculating change in limb volume, to enable critical analysis and comparison across studies.
Furthermore, where patients have bilateral oedema, and excess limb volume cannot be ascertained, any calculation of the percentage change in absolute limb volume will be affected by the size of the original pre-treatment limb. The same amount of reduction in volume may therefore be represented as a percentage which will vary depending on the starting absolute limb volume, and skewed by an overly large or small initial limb volume.
limitations
This audit was developed within the boundaries of normal clinical management, and provides insights for quality improvement and future research. Routinely used, non-validated methods were used to report skin and tissue conditions, and patient and professional experiences. Future research would require validated measures of skin and tissue condition, and quality of life tools adequately sensitive to changes associated with compression bandaging.
The practitioners taking part in the audit were highly experienced in compression bandaging. However, a relative lack of familiarity with the bandaging system in those only treating one patient in the audit, may have influenced the patient and practitioner experience. Notably, there were some difficulties in recruiting patients with unilateral 
Implications for practice and research
The findings of the audit indicate that the system is suitable for clinical use with patients who have unilateral and bilateral late stage lymphoedema. Practitioners found it easy to apply, and the simplicity of the system may reduce time spent bandaging. The combination of the foam roll and the unique textile properties of the cohesive inelastic bandages appears to provide a system that is comfortable and effective in reducing lymphoedema. It is less bulky than other systems where layers of wadding are used. As such, shoes can be worn, and there is limited restriction of movement. A patient withdrew from the audit due to increasing discomfort with the system. This patient had less frequent bandage change than advised in the audit protocol. It is possible that regular bandage change may help to address this issue. One practitioner noted: 'The system is really easy to use and I think it can be used by both generalists and specialists if they are familiar with Actico'. However, specific criteria are required to guide the use of the system. Bandage reapplication at 2-3 day intervals, particularly in the first week and at the early stages of oedema reduction, is advised. This also ensures that skin condition and changes in limb shape are regularly monitored.
Future research and evaluation of the system would provide additional evidence to inform practice. Any future research studies should address all components of the combined decongestive treatment approach, and consider variables that may influence outcome such as: tissue fibrosis, excess limb volume before treatment; and whether patients have been bandaged previously. There is as yet no evidence to show whether a greater reduction in 13 Similarly, the duration and extent of lymphoedema before treatment may be significant in determining outcome from bandaging, particularly if tissues are fibrotic and there is excess fat deposition.
Tissue changes such as fibrosis and lipodermatosclerosis are common in late stage lymphoedema. Lipodermatosclerosis is associated with an inflammatory process. Compression bandaging softens chronic fibrosis and lipodermatosclerosis, releases anti-inflammatory mediators, reduces capillary filtration and lymphatic load, and improves the microcirculation of the skin.
14 Further work is required to determine the influence of this bandaging system on the skin and tissues, and to validate methods for quantifying tissue density as an outcome measure.
Previously we showed that combining the soft foam and cohesive bandage applied in a figure-ofeight, provided significant variation in interface pressures between supine and standing.
6 Interface pressure variations achieved by specific bandaging materials may be important clinically in softening fibrosis and lipodermatosclerosis. They may also enhance the contraction of lymphangions, improving the lymph transport mechanisms.
2 More work is required to better understand the effect of compression on the lymphatic system and lymphoedematous limb.
Conclusions
This audit has indicated that existing bandage materials, available for many years, can be applied using specific techniques to achieve effective reduction in lymphoedema and favourable outcomes for patients and lymphoedema practitioners. Applied over a 12-day period, the system achieved comparable results to those established in a robust randomised controlled trial of bandaging over 18 days. 8 This indicated that the system may have specific benefits in shortening the treatment period, and reducing treatment costs. Anecdotal clinical experience has also shown that the foam roll can be reused over a course of bandaging, further reducing costs. The system is suitable for patients with unilateral and bilateral lymphoedema.
Development of this system has been based on an understanding of the science of compression therapy. It represents an innovative approach and an additional treatment option for experienced lymphoedema practitioners treating patients with late-stage lymphoedema. Future evaluation of the bandaging system, using validated outcome measures within a comprehensive research study is required. n
